高度創傷ケア市場 – 2030年までの世界予測

本レポートは、製品、創傷タイプ、エンドユーザー、および国に基づいて、高度創傷ケア市場を分析しています。また、市場の成長に影響を与える要因（促進要因、制約要因、機会、課題など）を分析するとともに、市場リーダーの競争環境の詳細を提供しています。さらに、ミクロ市場の成長傾向を分析しています。5つの地域（および各地域に属する国）に関連する市場セグメントの収益予測も提供しています。

The global advanced wound care market is projected to reach USD 19.32 billion by 2030 from USD 13.37 billion in 2025, at a CAGR of 7.6% during the forecast period.

世界の高度創傷ケア市場は、予測期間中に年平均成長率7.6%で成長し、2025年の133.7億米ドルから2030年には193.2億米ドルに達すると予測されています。

The advanced wound care market is projected to grow at a CAGR of 7.6% during the forecast period. The key factors contributing to the market growth include the increasing prevalence of diabetes, the rising cases of traumatic & burn injuries, and the expanding geriatric population with a subsequent rise in chronic wound conditions.

高度創傷ケア市場は、予測期間中に年平均成長率（CAGR）7.6%で成長すると予測されています。市場の成長を牽引する主な要因としては、糖尿病の有病率増加、外傷および火傷の増加、そして高齢化人口の増加に伴う慢性創傷の増加などが挙げられます。

By end user, the hospitals, ASCs, and wound care centers segment accounted for the largest share of the market in 2024.

By end user, the advanced wound care market is segmented into hospitals, ASCs, and wound care centers; home care settings; and other end users. In 2024, the hospitals, ASCs, and wound care centers segment accounted for the largest share of the market in 2024. The rising incidence of diabetic foot ulcers and surgical wounds primarily causes the need for advanced wound care products in hospitals. Hospital visits for wound care have also increased owing to the expanding geriatric population and the increasing incidence of chronic conditions, such as diabetes and vascular diseases. Hospitals and other advanced wound care centers can treat wounds quickly & effectively due to established protocols, knowledgeable medical staff, and the availability of advanced wound care products.

By wound type, the surgical & traumatic wounds segment accounted for the largest market share in 2024.

The market is segmented by wound type into surgical & traumatic wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, and burns & other wounds. The surgical & traumatic wounds segment accounted for the largest share of the advanced wound care market in 2024. The large share of this segment is attributed to the availability of advanced wound care products, which are particularly effective in managing these wounds, as they promote quicker recovery, reduce infection risks, and improve tissue growth. The increasing number of surgical procedures owing to the rising incidence of chronic diseases is also expected to contribute to market growth.

By region, the Asia Pacific is expected to grow at the highest CAGR during the forecast period.

The global advanced wound care market is segmented into five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. The growth of the Asia Pacific region can be attributed to the rising number of surgeries, road accidents, and burn cases, which is expected to influence the demand for advanced wound care therapies. The growing incidence of diabetes and rising cases of foot ulcers is also likely to fuel market growth. The Asia Pacific region offers high growth opportunities for players in the market owing to emerging growth economies.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1: 40%, Tier 2: 30%, and Tier 3: 35%
• By Designation: C Level: 27%, Director Level: 18%, and Others: 55%
• By Region: North America: 50%, Europe: 20%, the Asia Pacific: 20%, Latin America: 7%, and the Middle East & Africa: 3%

Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The key players operating in the advanced wound care market are Solventum (US), Smith+ Nephew (UK), Mölnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), B.Braun SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity, Aktiebolag (Sweden), AVERY DENNISON CORPORATION (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), Zimmer Biomet (US), and Bioventus (US).

Research Coverage

This report studies the advanced wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments pertaining to five regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established and entrants/smaller firms to gauge the market’s pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights into the following pointers: Analysis of key drivers (growing geriatric population, increasing cases of traumatic injuries, growing prevalence of chronic diseases, the rising incidence of burn injuries, and supportive government initiatives & reimbursement policies), restraints (high cost of advanced wound care products and the risks associated with the use of advanced wound care products), opportunities (Emerging economies and the rising technological advancements in advanced wound care products), and challenges (shortage of trained professionals and limited awareness of advanced wound care products in rural areas)

• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the advanced wound care market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the advanced wound care market
• Market Development: Comprehensive information on lucrative emerging regions
•  Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the advanced wound care market
• Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players

Table of Contents

1               INTRODUCTION              33

1.1           STUDY OBJECTIVES       33

1.2           MARKET DEFINITION   33

1.3           STUDY SCOPE   34

1.3.1        MARKETS COVERED AND REGIONAL SCOPE      34

1.3.2        INCLUSIONS AND EXCLUSIONS 35

1.3.3        YEARS CONSIDERED      36

1.4           CURRENCY CONSIDERED            36

1.5           STAKEHOLDERS               36

1.6           SUMMARY OF CHANGES               37

2               RESEARCH METHODOLOGY       38

2.1           RESEARCH DATA              38

2.1.1        SECONDARY DATA          38

2.1.1.1    Key data from secondary sources       39

2.1.2        PRIMARY DATA 40

2.1.2.1    Primary sources    40

2.1.2.2    Key industry insights           41

2.1.2.3    Key data from primary sources           41

2.1.2.4    Breakdown of primary interviews      42

2.2           MARKET SIZE ESTIMATION         43

2.2.1        BOTTOM-UP APPROACH              43

2.2.1.1    Approach 1: Company revenue estimation approach     43

2.2.1.2    Approach 2: Presentations of companies and primary interviews                 43

2.2.1.3    Approach 3: Primary interviews         44

2.2.1.4    Growth forecast    44

2.2.1.5    CAGR projections                 44

2.2.2        TOP-DOWN APPROACH                44

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 46

2.4           RESEARCH ASSUMPTIONS           47

2.4.1        STUDY-RELATED ASSUMPTIONS              47

2.4.2        PARAMETRIC ASSUMPTIONS     47

2.4.3        GROWTH RATE ASSUMPTIONS 47

2.5           RESEARCH LIMITATIONS             48

2.6           RISK ASSESSMENT           48

3               EXECUTIVE SUMMARY  49

4               PREMIUM INSIGHTS       53

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ADVANCED WOUND CARE MARKET       53

4.2           ASIA PACIFIC: ADVANCED WOUND CARE MARKET SHARE,  BY END USER AND COUNTRY  54

4.3           ADVANCED WOUND CARE MARKET, BY KEY COUNTRY                 55

4.4           ADVANCED WOUND CARE MARKET, BY REGION,  2025 VS. 2030 55

5               MARKET OVERVIEW       56

5.1           INTRODUCTION              56

5.2           MARKET DYNAMICS       56

5.2.1        DRIVERS               57

5.2.1.1    Growing geriatric population              57

5.2.1.2    Increasing cases of traumatic injuries                58

5.2.1.3    Growing prevalence of chronic diseases           58

5.2.1.4    Rising incidence of burn injuries       59

5.2.1.5    Government initiatives and reimbursement policies      60

5.2.2        RESTRAINTS      61

5.2.2.1    High cost of advanced wound care products    61

5.2.2.2    Risks associated with use of advanced wound care products                 61

5.2.3        OPPORTUNITIES              62

5.2.3.1    Growth opportunities in emerging economies 62

5.2.3.2    Technological advancement in wound care      63

5.2.4        CHALLENGES    63

5.2.4.1    Lack of trained healthcare professionals           63

5.2.4.2    Limited awareness in underdeveloped regions                 64

5.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            64

5.4           PRICING ANALYSIS          65

5.4.1        AVERAGE SELLING PRICE TREND, BY PRODUCT                 65

5.4.2        AVERAGE SELLING PRICE TREND, BY WOUND TYPE                 65

5.4.3        AVERAGE SELLING PRICE TREND, BY REGION   66

5.5           VALUE CHAIN ANALYSIS               66

5.6           SUPPLY CHAIN ANALYSIS             68

5.7           ECOSYSTEM ANALYSIS  69

5.8           INVESTMENT AND FUNDING SCENARIO               70

5.9           TECHNOLOGY ANALYSIS             70

5.9.1        KEY TECHNOLOGIES     70

5.9.1.1    Negative pressure wound therapy      70

5.9.2        COMPLEMENTARY TECHNOLOGIES       71

5.9.2.1    Micropore particle technology            71

5.9.3        ADJACENT TECHNOLOGIES       71

5.9.3.1    Telemedicine and mobile health (MHealth)    71

5.10         PATENT ANALYSIS          72

5.11         TRADE ANALYSIS             73

5.11.1      IMPORT DATA (HS CODE 300510)              74

5.11.2      EXPORT DATA (HS CODE 300510)              74

5.12         KEY CONFERENCES AND EVENTS, 2025–2026        75

5.13         CASE STUDY ANALYSIS 76

5.13.1      CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL ADVANCED WOUND CARE      76

5.13.2      CASE STUDY 2: EVALUATION OF NEW HYDROCOLL HYDROCOLLOID DRESSING IN WOUND CARE   76

5.13.3      CASE STUDY 3: SUPPORTED SELF-MANAGEMENT OF HARD-TO-HEAL PRESSURE ULCERS USING A SIMPLE 3-STEP FRAMEWORK DEVELOPED BY COLOPLAST         77

5.14         REGULATORY LANDSCAPE         78

5.14.1      REGULATORY ANALYSIS               78

5.14.1.1  North America      78

5.14.1.1.1                US           78

5.14.1.1.2                Canada   78

5.14.1.2  Europe   78

5.14.1.2.1                Germany                 79

5.14.1.2.2                UK          79

5.14.1.2.3                France    79

5.14.1.3  Asia Pacific            79

5.14.1.3.1                China      79

5.14.1.3.2                Japan      79

5.14.1.3.3                India       80

5.14.1.4  Latin America       80

5.14.1.5  Middle East           80

5.14.2      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             81

5.14.2.1  North America      81

5.14.2.2  Europe   81

5.14.2.3  Asia Pacific            81

5.14.2.4  Latin America       82

5.14.2.5  Rest of the World 82

5.15         PORTER’S FIVE FORCES ANALYSIS           83

5.15.1      BARGAINING POWER OF SUPPLIERS       84

5.15.2      BARGAINING POWER OF BUYERS             84

5.15.3      THREAT OF NEW ENTRANTS      84

5.15.4      THREAT OF SUBSTITUTES          84

5.15.5      INTENSITY OF COMPETITIVE RIVALRY 84

5.16         KEY STAKEHOLDERS AND BUYING CRITERIA     84

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           85

5.16.2      BUYING CRITERIA           85

5.17         IMPACT OF AI ON ADVANCED WOUND CARE MARKET                 86

5.17.1      INTRODUCTION              86

5.17.2      MARKET POTENTIAL OF AI IN ADVANCED WOUND CARE MARKET  86

5.17.3      AI USE CASES     87

5.17.4      KEY COMPANIES IMPLEMENTING AI      87

5.17.5      FUTURE OF AI IN ADVANCED WOUND CARE MARKET                 88

5.18         IMPACT OF US TARIFF REGULATION ON ADVANCED WOUND CARE MARKET 88

5.18.1      INTRODUCTION              88

5.18.2      KEY TARIFF RATES          89

5.18.3      PRICE IMPACT ANALYSIS             89

5.18.4      KEY IMPACTS ON COUNTRY/REGION    90

5.18.4.1  North America      90

5.18.4.2  Europe   90

5.18.4.3  Asia Pacific            90

5.18.5      IMPACT ON END-USE INDUSTRIES          90

5.18.5.1  Hospitals, ASCs, and wound care centers         91

6               ADVANCED WOUND CARE MARKET, BY PRODUCT                 92

6.1           INTRODUCTION              93

6.2           DRESSINGS         93

6.2.1        FOAM DRESSINGS           96

6.2.1.1    Silicone dressings 100

6.2.1.1.1 Ability to expedite wound closure and reduce risk of maceration to drive market      100

6.2.1.2    Non-silicone dressings        102

6.2.1.2.1 Advantages such as scar removal and wound healing to drive demand  102

6.2.2        HYDROCOLLOID DRESSINGS     105

6.2.2.1    Ability to promote granulation and formation of new tissues in open wounds to boost adoption          105

6.2.3        FILM DRESSINGS              108

6.2.3.1    Non-absorbable nature of film dressings to limit adoption                 108

6.2.4        ALGINATE DRESSINGS  110

6.2.4.1    Growing incidence of pressure and diabetic foot ulcers to fuel growth    110

6.2.5        HYDROGEL DRESSINGS                113

6.2.5.1    Ability to provide relief and cooling effect on skin to drive use of hydrogel dressings                113

6.2.6        COLLAGEN DRESSINGS 115

6.2.6.1    Favorable reimbursement scenario for collagen dressings to support market      115

6.2.7        HYDROFIBER DRESSINGS             118

6.2.7.1    Combination of properties of hydrocolloids and alginates to boost adoption of hydrofiber dressings       118

6.2.8        WOUND CONTACT LAYERS         121

6.2.8.1    Ability to protect wound beds from bacterial and fungal growth to drive growth      121

6.2.9        SUPERABSORBENT DRESSINGS 123

6.2.9.1    Use of superabsorbent dressings for fragile skin to promote growth    123

6.2.10      OTHER ADVANCED DRESSINGS                126

6.3           DEVICES & ACCESSORIES             130

6.3.1        NPWT DEVICES & ACCESSORIES                132

6.3.1.1    Growing adoption of single-use NPWT devices in home care to drive growth          132

6.3.2        DEBRIDEMENT DEVICES & ACCESSORIES             135

6.3.2.1    Development of novel technologies to drive market       135

6.3.3        WOUND ASSESSMENT & MONITORING DEVICES                 138

6.3.3.1    Potential cost-reducing capabilities of wound assessment & monitoring devices to boost adoption                138

6.3.4        OTHER DEVICES & ACCESSORIES             141

6.4           BIOLOGICAL SKIN SUBSTITUTES             144

6.4.1        HUMAN DONOR TISSUE-DERIVED PRODUCTS  148

6.4.1.1    High efficacy of human donor tissue-derived products to support market demand     148

6.4.2        ACELLULAR ANIMAL-DERIVED PRODUCTS         149

6.4.2.1    Recognition of importance of ECM in wound treatment to drive development of acellular wound care biologics                149

6.4.3        BIOSYNTHETIC PRODUCTS        150

6.4.3.1    Increased bioburden of infected wounds to drive development of biosynthetic wound care products     150

6.5           TOPICAL AGENTS            151

6.5.1        COST-EFFECTIVENESS AND EASE OF USE IN HOME CARE SETTINGS TO DRIVE DEMAND      151

7               ADVANCED WOUND CARE MARKET, BY WOUND TYPE                 155

7.1           INTRODUCTION              156

7.2           SURGICAL & TRAUMATIC WOUNDS        156

7.2.1        RISING VOLUME OF SURGICAL PROCEDURES TO DRIVE MARKET               156

7.3           DIABETIC FOOT ULCERS              160

7.3.1        RISING DIABETES INCIDENCE TO DRIVE MARKET                 160

7.4           PRESSURE ULCERS          164

7.4.1        GROWING GERIATRIC POPULATION TO DRIVE MARKET                 164

7.5           VENOUS LEG ULCERS    167

7.5.1        RISING PREVALENCE OF OBESITY TO DRIVE MARKET                 167

7.6           BURNS & OTHER WOUNDS          170

7.6.1        HIGH INCIDENCE OF BURN INJURIES IN DEVELOPING REGIONS TO SUPPORT MARKET GROWTH          170

8               ADVANCED WOUND CARE MARKET, BY END USER                 174

8.1           INTRODUCTION              175

8.2           HOSPITALS, ASCS, AND WOUND CARE CENTERS                 175

8.2.1        INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE GROWTH         175

8.3           HOME CARE SETTINGS 179

8.3.1        DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE TO ENSURE MARKET GROWTH                 179

8.4           OTHER END USERS         182

9               ADVANCED WOUND CARE MARKET, BY REGION                 186

9.1           INTRODUCTION              187

9.2           NORTH AMERICA             187

9.2.1        MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 188

9.2.2        US           192

9.2.2.1    Rising diabetes prevalence and supportive reimbursement policies to drive market       192

9.2.3        CANADA               195

9.2.3.1    Government-backed efforts supporting market development                 195

9.3           EUROPE               198

9.3.1        MACROECONOMIC OUTLOOK FOR EUROPE      199

9.3.2        GERMANY           203

9.3.2.1    Germany sees rising diabetes cases and chronic wound burden                 203

9.3.3        UK          206

9.3.3.1    Increase in R&D activity to drive market          206

9.3.4        FRANCE                209

9.3.4.1    Rising chronic wound cases to drive market expansion  209

9.3.5        ITALY    212

9.3.5.1    Emerging market for advanced wound care in Europe   212

9.3.6        SPAIN    215

9.3.6.1    Rising life expectancy and aging population to drive demand                 215

9.3.7        RUSSIA 218

9.3.7.1    Government initiatives to raise diabetes awareness to support market expansion 218

9.3.8        REST OF EUROPE             221

9.4           ASIA PACIFIC     224

9.4.1        MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 225

9.4.2        CHINA  230

9.4.2.1    Increasing incidence of diabetic foot ulcers (DFUs) to drive growth    230

9.4.3        JAPAN   233

9.4.3.1    Evolving healthcare delivery and infrastructure landscape to fuel market    233

9.4.4        INDIA    236

9.4.4.1    Booming medical tourism to speed up growth 236

9.4.5        AUSTRALIA         239

9.4.5.1    Growing medical manufacturing companies to drive market                 239

9.4.6        SOUTH KOREA  242

9.4.6.1    Increasing healthcare spending to sustain growth           242

9.4.7        SINGAPORE        245

9.4.7.1    Increasing awareness and focus on advanced wound care therapies to facilitate growth               245

9.4.8        REST OF ASIA PACIFIC   248

9.5           LATIN AMERICA                252

9.5.1        MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 253

9.5.2        BRAZIL 256

9.5.2.1    Largest healthcare sector to drive market         256

9.5.3        MEXICO                259

9.5.3.1    Expanding hospital infrastructure to aid growth              259

9.5.4        REST OF LATIN AMERICA             262

9.6           MIDDLE EAST & AFRICA                265

9.6.1        GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 265

9.6.2        MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 266

10            COMPETITIVE LANDSCAPE         270

10.1         OVERVIEW          270

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 270

10.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ADVANCED WOUND CARE MARKET       270

10.3         REVENUE ANALYSIS, 2022–2024  272

10.4         MARKET SHARE ANALYSIS, 2024                 272

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 275

10.5.1      STARS   276

10.5.2      EMERGING LEADERS     276

10.5.3      PERVASIVE PLAYERS      276

10.5.4      PARTICIPANTS 276

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         278

10.5.5.1  Company footprint               278

10.5.5.2  Region footprint   279

10.5.5.3  Product footprint  280

10.5.5.4  Wound type footprint           281

10.5.5.5  End user footprint                 282

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024        283

10.6.1      PROGRESSIVE COMPANIES         283

10.6.2      RESPONSIVE COMPANIES            283

10.6.3      DYNAMIC COMPANIES  283

10.6.4      STARTING BLOCKS         283

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024                 285

10.6.5.1  Detailed list of key startups/SMEs    285

10.6.5.2  Competitive benchmarking of key startups/SMEs          285

10.7         COMPANY VALUATION AND FINANCIAL METRICS                 286

10.7.1      COMPANY VALUATION 286

10.7.2      FINANCIAL METRICS      286

10.8         BRAND/PRODUCT COMPARISON             287

10.9         COMPETITIVE SCENARIO             287

10.9.1      PRODUCT LAUNCHES AND APPROVALS               287

10.9.2      DEALS  289

10.9.3      EXPANSIONS     290

10.9.4      OTHER DEVELOPMENTS              291

11            COMPANY PROFILES      292

11.1         KEY PLAYERS     292

11.1.1      SOLVENTUM     292

11.1.1.1  Business overview 292

11.1.1.2  Products/Solutions/Services offered 293

11.1.1.3  Recent developments           296

11.1.1.3.1                Product launches & approvals            296

11.1.1.3.2                Other developments             296

11.1.1.4  MnM view              296

11.1.1.4.1                Right to win           296

11.1.1.4.2                Strategic choices   296

11.1.1.4.3                Weaknesses & competitive threats     297

11.1.2      SMITH+NEPHEW              298

11.1.2.1  Business overview 298

11.1.2.2  Products/Solutions/Services offered 299

11.1.2.3  Recent developments           301

11.1.2.3.1                Product launches & approvals            301

11.1.2.3.2                Deals      302

11.1.2.3.3                Expansions             302

11.1.2.3.4                Other developments             302

11.1.2.4  MnM view              303

11.1.2.4.1                Right to win           303

11.1.2.4.2                Strategic choices   303

11.1.2.4.3                Weaknesses & competitive threats     303

11.1.3      MÖLNLYCKE AB               304

11.1.3.1  Business overview 304

11.1.3.2  Products/Solutions/Services offered 305

11.1.3.3  Recent developments           307

11.1.3.3.1                Deals      307

11.1.3.3.2                Other developments             308

11.1.3.4  MnM view              308

11.1.3.4.1                Right to win           308

11.1.3.4.2                Strategic choices   308

11.1.3.4.3                Weaknesses & competitive threats     308

11.1.4      CONVATEC GROUP PLC                309

11.1.4.1  Business overview 309

11.1.4.2  Products/Solutions/Services offered 310

11.1.4.3  Recent developments           311

11.1.4.3.1                Product launches & approvals            311

11.1.4.3.2                Deals      312

11.1.4.4  MnM view              312

11.1.4.4.1                Right to win           312

11.1.4.4.2                Strategic choices   312

11.1.4.4.3                Weaknesses & competitive threats     312

11.1.5      COLOPLAST GROUP       313

11.1.5.1  Business overview 313

11.1.5.2  Products/Solutions/Services offered 314

11.1.5.3  Recent developments           316

11.1.5.3.1                Product launches & approvals            316

11.1.5.3.2                Deals      316

11.1.5.4  MnM view              317

11.1.5.4.1                Right to win           317

11.1.5.4.2                Strategic choices   317

11.1.5.4.3                Weaknesses & competitive threats     317

11.1.6      ORGANOGENESIS INC.  318

11.1.6.1  Business overview 318

11.1.6.2  Products/Solutions/Services offered 319

11.1.6.3  Recent developments           319

11.1.6.3.1                Product launches & approvals            319

11.1.6.3.2                Expansions             319

11.1.7      PAUL HARTMANN AG    320

11.1.7.1  Business overview 320

11.1.7.2  Products/Solutions/Services offered 321

11.1.7.3  Recent developments           323

11.1.7.3.1                Deals      323

11.1.8      CARDINAL HEALTH        324

11.1.8.1  Business overview 324

11.1.8.2  Products/Solutions/Services offered 325

11.1.8.3  Recent developments           328

11.1.8.3.1                Deals      328

11.1.8.3.2                Expansions             328

11.1.9      MIMEDX GROUP, INC.   329

11.1.9.1  Business overview 329

11.1.9.2  Products/Solutions/Services offered 330

11.1.9.3  Recent developments           330

11.1.9.3.1                Product launches & approvals            330

11.1.10   OWENS & MINOR              331

11.1.10.1                 Business overview 331

11.1.10.2                 Products/Solutions/Services offered 332

11.1.10.3                 Recent developments           332

11.1.10.3.1             Deals      332

11.1.10.3.2             Other developments             333

11.1.11   B. BRAUN SE       334

11.1.11.1                 Business overview 334

11.1.11.2                 Products/Solutions/Services offered 335

11.1.11.3                 Recent developments           336

11.1.11.3.1             Expansions             336

11.1.11.3.2             Other developments             336

11.1.12   ESSITY AKTIEBOLAG      337

11.1.12.1                 Business overview 337

11.1.12.2                 Products/Solutions/Services offered 338

11.1.12.3                 Recent developments           340

11.1.12.3.1             Other developments             340

11.1.13   INTEGRA LIFESCIENCES CORPORATION               341

11.1.13.1                 Business overview 341

11.1.13.2                 Products/Solutions/Services offered 342

11.1.13.3                 Recent developments           343

11.1.13.3.1             Product launches & approvals            343

11.1.13.3.2             Other developments             344

11.1.14   AVERY DENNISON CORPORATION           345

11.1.14.1                 Business overview 345

11.1.14.2                 Products/Solutions/Services offered 346

11.1.14.3                 Recent developments           347

11.1.14.3.1             Expansions             347

11.1.15   MATIV HOLDINGS, INC.                348

11.1.15.1                 Business overview 348

11.1.15.2                 Products/Solutions/Services offered 349

11.1.15.3                 Recent developments           350

11.1.15.3.1             Deals      350

11.1.16   BIOVENTUS       351

11.1.16.1                 Business overview 351

11.1.16.2                 Products/Solutions/Services offered 352

11.1.16.3                 Recent developments           353

11.1.16.3.1             Deals      353

11.1.16.3.2             Other developments             353

11.1.17   ZIMMER BIOMET             354

11.1.17.1                 Business overview 354

11.1.17.2                 Products/Solutions/Services offered 355

11.1.17.3                 Recent developments           356

11.1.17.3.1             Deals      356

11.2         OTHER PLAYERS              357

11.2.1      LOHMANN & RAUSCHER GMBH & CO. KG             357

11.2.2      MEDLINE INDUSTRIES, LP           358

11.2.3      DEROYAL INDUSTRIES, INC.       359

11.2.4      WINNER MEDICAL CO., LTD.      360

11.2.5      ADVANCIS (UK)                 361

11.2.6      MIL LABORATORIES PVT. LTD. 362

11.2.7      PENSAR MEDICAL            363

11.2.8      HAROMED BV   364

11.2.9      URGO GROUP   365

11.2.10   DIRECT HEALTHCARE GROUP  365

11.2.11   DERMARITE INDUSTRIES, LLC.  366

11.2.12   MEDAXIS LLC    367

11.2.13   GENTELL             368

12            APPENDIX           369

12.1         DISCUSSION GUIDE        369

12.2         KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL                372

12.3         CUSTOMIZATION OPTIONS        374

12.4         RELATED REPORTS         374

12.5         AUTHOR DETAILS           375

LIST OF TABLES

TABLE 1                ADVANCED WOUND CARE MARKET: INCLUSIONS AND EXCLUSIONS 35

TABLE 2                ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT       48

TABLE 3                POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023        57

TABLE 4                ROAD ACCIDENT DEMOGRAPHIC, 2022 58

TABLE 5                CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017–DECEMBER 2023                59

TABLE 6                RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS             62

TABLE 7                STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024              62

TABLE 8                AVERAGE SELLING PRICING TREND OF ADVANCED WOUND CARE PRODUCTS,  2023–2025          65

TABLE 9                AVERAGE SELLING PRICE TREND AMONG KEY PLAYERS, BY WOUND TYPE,

2023–2025              65

TABLE 10              AVERAGE SELLING PRICE TREND KEY PLAYERS, BY REGION, 2023–2025    66

TABLE 11              ADVANCED WOUND CARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM       69

TABLE 12              ADVANCED WOUND CARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS,  2023–2025                 73

TABLE 13              IMPORT DATA (HS CODE 300510), BY COUNTRY, 2020–2024 (USD MILLION)            74

TABLE 14              EXPORT DATA (HS CODE 300510), BY COUNTRY, 2020–2024 (USD MILLION)            74

TABLE 15              ADVANCED WOUND CARE MARKET: KEY CONFERENCES AND EVENTS,

APRIL 2025–DECEMBER 2026        75

TABLE 16              TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN         80

TABLE 17              NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 81

TABLE 18              EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 81

TABLE 19              ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 81

TABLE 20              LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 82

TABLE 21              REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             82

TABLE 22              ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 83

TABLE 23              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ADVANCED WOUND CARE PRODUCTS (%)                 85

TABLE 24              KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS           86

TABLE 25              US ADJUSTED RECIPROCAL TARIFF RATES                 89

TABLE 26              ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     93

TABLE 27             ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            94

TABLE 28             ADVANCED WOUND CARE DRESSINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            94

TABLE 29              NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,  2023–2030 (USD MILLION)                 95

TABLE 30              EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 31              ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,  2023–2030 (USD MILLION)                 96

TABLE 32              LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY,  2023–2030 (USD MILLION)                 96

TABLE 33              KEY PRODUCTS IN FOAM DRESSINGS MARKET                 97

TABLE 34              FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 98

TABLE 35              FOAM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)       98

TABLE 36              NORTH AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            98

TABLE 37              EUROPE: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     99

TABLE 38              ASIA PACIFIC: FOAM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            99

TABLE 39              LATIN AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            100

TABLE 40              SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            100

TABLE 41              NORTH AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 42              EUROPE: SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            101

TABLE 43              ASIA PACIFIC: SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            102

TABLE 44             LATIN AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            102

TABLE 45              NON-SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          103

TABLE 46              NORTH AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            103

TABLE 47              EUROPE: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            104

TABLE 48              ASIA PACIFIC: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            104

TABLE 49              LATIN AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            105

TABLE 50              KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET      105

TABLE 51              HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          106

TABLE 52              NORTH AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            106

TABLE 53             EUROPE: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            107

TABLE 54              ASIA PACIFIC: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            107

TABLE 55              LATIN AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            108

TABLE 56              KEY PRODUCTS IN FILM DRESSINGS MARKET                 108

TABLE 57              FILM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)       109

TABLE 58              NORTH AMERICA: FILM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            109

TABLE 59              EUROPE: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     109

TABLE 60              ASIA PACIFIC: FILM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 61              LATIN AMERICA: FILM DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 62              KEY PRODUCTS IN ALGINATE DRESSINGS MARKET               111

TABLE 63              ALGINATE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            111

TABLE 64              NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 65              EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            112

TABLE 66              ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            112

TABLE 67              LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            113

TABLE 68              KEY PRODUCTS IN HYDROGEL DRESSINGS MARKET               113

TABLE 69              HYDROGEL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            114

TABLE 70              NORTH AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 71              EUROPE: HYDROGEL DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            114

TABLE 72              ASIA PACIFIC: HYDROGEL DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            115

TABLE 73              LATIN AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            115

TABLE 74              KEY PRODUCTS IN COLLAGEN DRESSINGS MARKET               116

TABLE 75              COLLAGEN DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            116

TABLE 76              NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            117

TABLE 77              EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            117

TABLE 78              ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 79              LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            118

TABLE 80              KEY PRODUCTS IN HYDROFIBER DRESSINGS MARKET               119

TABLE 81              HYDROFIBER DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)            119

TABLE 82              NORTH AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            119

TABLE 83              EUROPE: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            120

TABLE 84              ASIA PACIFIC: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            120

TABLE 85              LATIN AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            121

TABLE 86              KEY PRODUCTS IN WOUND CONTACT LAYERS MARKET               121

TABLE 87              WOUND CONTACT LAYERS MARKET, BY REGION, 2023–2030 (USD MILLION)          122

TABLE 88              NORTH AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 89              EUROPE: WOUND CONTACT LAYERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 90              ASIA PACIFIC: WOUND CONTACT LAYERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            123

TABLE 91              LATIN AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            123

TABLE 92              KEY PRODUCTS IN SUPERABSORBENT DRESSINGS MARKET      124

TABLE 93              SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          124

TABLE 94              NORTH AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            125

TABLE 95              EUROPE: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            125

TABLE 96              ASIA PACIFIC: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          126

TABLE 97              LATIN AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          126

TABLE 98              KEY PRODUCTS IN OTHER ADVANCED DRESSINGS MARKET      127

TABLE 99              OTHER ADVANCED DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          128

TABLE 100            NORTH AMERICA: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            128

TABLE 101            EUROPE: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            128

TABLE 102            ASIA PACIFIC: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            129

TABLE 103            LATIN AMERICA: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)          129

TABLE 104            ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,

2023–2030 (USD MILLION)            130

TABLE 105            DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)            130

TABLE 106            NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            131

TABLE 107            EUROPE: DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            131

TABLE 108            ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            132

TABLE 109            LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            132

TABLE 110            KEY PRODUCTS IN NPWT DEVICES & ACCESSORIES MARKET 133

TABLE 111            NPWT DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION)          134

TABLE 112            NORTH AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 113            EUROPE: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            134

TABLE 114            ASIA PACIFIC: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            135

TABLE 115            LATIN AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            135

TABLE 116            KEY PRODUCTS IN DEBRIDEMENT DEVICES & ACCESSORIES MARKET 136

TABLE 117            DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY REGION,

2023–2030 (USD MILLION)            136

TABLE 118            NORTH AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               137

TABLE 119            EUROPE: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            137

TABLE 120            ASIA PACIFIC: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY,  2023–2030 (USD MILLION)            138

TABLE 121            LATIN AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY,  2023–2030 (USD MILLION)            138

TABLE 122            KEY PRODUCTS IN WOUND ASSESSMENT & MONITORING DEVICES MARKET              139

TABLE 123            WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            139

TABLE 124            NORTH AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               139

TABLE 125            EUROPE: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY,  2023–2030 (USD MILLION)                 140

TABLE 126            ASIA PACIFIC: WOUND ASSESSMENT & MONITORING DEVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               140

TABLE 127            LATIN AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET,

BY COUNTRY, 2023–2030 (USD MILLION)               141

TABLE 128            KEY PRODUCTS IN OTHER DEVICES & ACCESSORIES MARKET 142

TABLE 129            OTHER DEVICES & ACCESSORIES MARKET, BY REGION,

2023–2030 (USD MILLION)            143

TABLE 130            NORTH AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,  2023–2030 (USD MILLION)            143

TABLE 131            EUROPE: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            143

TABLE 132            ASIA PACIFIC: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 133            LATIN AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            144

TABLE 134            KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET 145

TABLE 135            BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION)                145

TABLE 136            BIOLOGICAL SKIN SUBSTITUTES MARKET, BY REGION, 2023–2030 (USD MILLION)          146

TABLE 137            NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            146

TABLE 138            EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 139            ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            147

TABLE 140            LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            148

TABLE 141            KEY PRODUCTS IN HUMAN DONOR TISSUE MARKET               148

TABLE 142            HUMAN DONOR TISSUE MARKET, BY REGION, 2023–2030 (USD MILLION)            149

TABLE 143            KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED MARKET           149

TABLE 144            ACELLULAR ANIMAL-DERIVED MARKET, BY REGION, 2023–2030 (USD MILLION)          150

TABLE 145            KEY PRODUCTS IN BIOSYNTHETIC MARKET                 150

TABLE 146            BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION)          151

TABLE 147            KEY PRODUCTS IN TOPICAL AGENTS MARKET                 152

TABLE 148            TOPICAL AGENTS MARKET, BY REGION, 2023–2030 (USD MILLION)       152

TABLE 149            NORTH AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            153

TABLE 150            EUROPE: TOPICAL AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)     153

TABLE 151            ASIA PACIFIC: TOPICAL AGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 152            LATIN AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            154

TABLE 153            ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION)             156

TABLE 154            ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,

BY REGION, 2023–2030 (USD MILLION)   158

TABLE 155            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)            158

TABLE 156            EUROPE: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS,  BY COUNTRY, 2023–2030 (USD MILLION)       159

TABLE 157            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)            159

TABLE 158            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION)            160

TABLE 159            TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2024 (USD MILLION)  161

TABLE 160            NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY,

2023–2030 (THOUSANDS)              161

TABLE 161            ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY REGION,  2023–2030 (USD MILLION)            162

TABLE 162            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,  BY COUNTRY, 2023–2030 (USD MILLION)       162

TABLE 163            EUROPE: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               163

TABLE 164            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               163

TABLE 165            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS,  BY COUNTRY, 2023–2030 (USD MILLION)       164

TABLE 166            ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY REGION,

2023–2030 (USD MILLION)            165

TABLE 167            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               165

TABLE 168            EUROPE: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 169            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               166

TABLE 170            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               167

TABLE 171            ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY REGION,

2023–2030 (USD MILLION)            168

TABLE 172            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS,  BY COUNTRY, 2023–2030 (USD MILLION) 168

TABLE 173            EUROPE ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 174            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               169

TABLE 175            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS,

BY COUNTRY, 2023–2030 (USD MILLION)               170

TABLE 176            ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY REGION,  2023–2030 (USD MILLION)                 171

TABLE 177            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS,  BY COUNTRY, 2023–2030 (USD MILLION)       171

TABLE 178            EUROPE: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS,

BY COUNTRY, 2023–2030 (USD MILLION)               172

TABLE 179            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS,  BY COUNTRY, 2023–2030 (USD MILLION)       172

TABLE 180            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS,  BY COUNTRY, 2023–2030 (USD MILLION)       173

TABLE 181            ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                175

TABLE 182            HOSPITALS PER CAPITA, BY COUNTRY, 2024                 177

TABLE 183            ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY REGION, 2023–2030 (USD MILLION)            177

TABLE 184            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)               178

TABLE 185            EUROPE: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)     178

TABLE 186            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 187            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION)               179

TABLE 188            ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY REGION,  2023–2030 (USD MILLION)                 180

TABLE 189            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS,  BY COUNTRY, 2023–2030 (USD MILLION) 181

TABLE 190            EUROPE: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION)            181

TABLE 191            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS,

BY COUNTRY, 2023–2030 (USD MILLION)               182

TABLE 192            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS,  BY COUNTRY, 2023–2030 (USD MILLION) 182

TABLE 193            ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY REGION,

2023–2030 (USD MILLION)            183

TABLE 194            NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               184

TABLE 195            EUROPE: ADVANCED WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               184

TABLE 196            ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY, 2023–2030 (USD MILLION)               185

TABLE 197            LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2030 (USD MILLION)               185

TABLE 198          ADVANCED WOUND CARE MARKET, BY REGION, 2023–2030 (USD MILLION)            187

TABLE 199            NORTH AMERICA: MACROECONOMIC INDICATORS      188

TABLE 200            NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            189

TABLE 201            NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            190

TABLE 202            NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 190

TABLE 203            NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            191

TABLE 204            NORTH AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         191

TABLE 205            NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY WOUND TYPE,  2023–2030 (USD MILLION)            191

TABLE 206            NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            192

TABLE 207            US: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     193

TABLE 208            US: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            193

TABLE 209            US: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)       194

TABLE 210            US: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 194

TABLE 211            US: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            194

TABLE 212            US: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)                195

TABLE 213            ESTIMATED PREVALENCE AND COST OF DIABETES           195

TABLE 214            CANADA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            196

TABLE 215            CANADA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            196

TABLE 216            CANADA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            197

TABLE 217            CANADA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 197

TABLE 218            CANADA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            198

TABLE 219            CANADA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            198

TABLE 220            EUROPE: MACROECONOMIC INDICATORS                 199

TABLE 221            EUROPE: ADVANCED WOUND CARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            200

TABLE 222            EUROPE: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            200

TABLE 223            EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            201

TABLE 224            EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            201

TABLE 225            EUROPE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 202

TABLE 226            EUROPE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            202

TABLE 227            EUROPE: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            203

TABLE 228            GERMANY: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            204

TABLE 229            GERMANY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            204

TABLE 230          GERMANY: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            205

TABLE 231            GERMANY: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)                 205

TABLE 232            GERMANY: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            205

TABLE 233            GERMANY: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            206

TABLE 234            UK: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     207

TABLE 235            UK: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            207

TABLE 236            UK: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)       208

TABLE 237            UK: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 208

TABLE 238            UK: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            208

TABLE 239            UK: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION)     209

TABLE 240            FRANCE: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            209

TABLE 241            FRANCE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            210

TABLE 242            FRANCE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            210

TABLE 243            FRANCE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 211

TABLE 244            FRANCE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            211

TABLE 245            FRANCE: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            212

TABLE 246            ITALY: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            213

TABLE 247            ITALY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            213

TABLE 248            ITALY: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            214

TABLE 249            ITALY: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 214

TABLE 250            ITALY: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            214

TABLE 251            ITALY: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            215

TABLE 252            SPAIN: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            216

TABLE 253            SPAIN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030(USD MILLION)              216

TABLE 254            SPAIN: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            217

TABLE 255            SPAIN: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 217

TABLE 256            SPAIN: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)          217

TABLE 257            SPAIN: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            218

TABLE 258            RUSSIA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            219

TABLE 259            RUSSIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            219

TABLE 260            RUSSIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            220

TABLE 261            RUSSIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 220

TABLE 262            RUSSIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            220

TABLE 263            RUSSIA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            221

TABLE 264            REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          222

TABLE 265            REST OF EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 222

TABLE 266            REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            223

TABLE 267            REST OF EUROPE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION)            223

TABLE 268            REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            224

TABLE 269            REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            224

TABLE 270            ASIA PACIFIC: KEY MACROECONOMIC INDICATORS      225

TABLE 271            ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            227

TABLE 272            ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            227

TABLE 273            ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)          228

TABLE 274            ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                228

TABLE 275            ASIA PACIFIC: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,

BY TYPE,  2023–2030 (USD MILLION)      229

TABLE 276            ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            229

TABLE 277            ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            230

TABLE 278            CHINA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            231

TABLE 279            CHINA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            231

TABLE 280            CHINA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            232

TABLE 281            CHINA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 232

TABLE 282            CHINA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            233

TABLE 283            CHINA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            233

TABLE 284            JAPAN: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            234

TABLE 285            JAPAN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            234

TABLE 286            JAPAN: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            235

TABLE 287            JAPAN: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 235

TABLE 288            JAPAN: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            235

TABLE 289            JAPAN: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            236

TABLE 290            INDIA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            237

TABLE 291            INDIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            237

TABLE 292            INDIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            238

TABLE 293            INDIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 238

TABLE 294            INDIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)          239

TABLE 295            INDIA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)          239

TABLE 296            AUSTRALIA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            240

TABLE 297            AUSTRALIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)          240

TABLE 298            AUSTRALIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                241

TABLE 299            AUSTRALIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,

BY TYPE,  2023–2030 (USD MILLION)      241

TABLE 300            AUSTRALIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            241

TABLE 301            AUSTRALIA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            242

TABLE 302            SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)          243

TABLE 303            SOUTH KOREA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)          243

TABLE 304            SOUTH KOREA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                244

TABLE 305            SOUTH KOREA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         244

TABLE 306            SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            245

TABLE 307            SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            245

TABLE 308            SINGAPORE: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            246

TABLE 309            SINGAPORE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            246

TABLE 310            SINGAPORE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                247

TABLE 311            SINGAPORE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,

BY TYPE,  2023–2030 (USD MILLION)      247

TABLE 312            SINGAPORE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)          248

TABLE 313            SINGAPORE: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            248

TABLE 314            REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            249

TABLE 315            REST OF ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 250

TABLE 316            REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            250

TABLE 317            REST OF ASIA PACIFIC: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,  BY TYPE, 2023–2030 (USD MILLION) 251

TABLE 318            REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,  2023–2030 (USD MILLION)                 251

TABLE 319            REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)          252

TABLE 320            LATIN AMERICA: KEY MACROECONOMIC INDICATORS      253

TABLE 321            LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            253

TABLE 322            LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            254

TABLE 323            LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            254

TABLE 324            LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)                255

TABLE 325            LATIN AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET,

BY TYPE, 2023–2030 (USD MILLION)         255

TABLE 326            LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            256

TABLE 327            LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)          256

TABLE 328            BRAZIL: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            257

TABLE 329            BRAZIL: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)          257

TABLE 330            BRAZIL: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            258

TABLE 331            BRAZIL: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 258

TABLE 332            BRAZIL: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            259

TABLE 333            BRAZIL: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            259

TABLE 334            MEXICO: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            260

TABLE 335            MEXICO: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            260

TABLE 336            MEXICO: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            261

TABLE 337            MEXICO: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE,  2023–2030 (USD MILLION)                 261

TABLE 338            MEXICO: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2023–2030 (USD MILLION)            261

TABLE 339            MEXICO: ADVANCED WOUND CARE MARKET, BY END USER,

2023–2030 (USD MILLION)            262

TABLE 340            REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT,  2023–2030 (USD MILLION)                 262

TABLE 341            REST OF LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET,

BY TYPE,  2023–2030 (USD MILLION)      263

TABLE 342            REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)            263

TABLE 343            REST OF LATIN AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 264

TABLE 344            REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,  2023–2030 (USD MILLION)                 264

TABLE 345            REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY END USER,  2023–2030 (USD MILLION)                 265

TABLE 346            MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS              266

TABLE 347            MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            266

TABLE 348            MIDDLE EAST & AFRICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE,  2023–2030 (USD MILLION)                 267

TABLE 349            MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE,

2023–2030 (USD MILLION)          267

TABLE 350            MIDDLE EAST & AFRICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268

TABLE 351            MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE,  2023–2030 (USD MILLION)                 268

TABLE 352            MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY END USER,  2023–2030 (USD MILLION)                 269

TABLE 353            ADVANCED WOUND CARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–APRIL 2025 270

TABLE 354            ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION           273

TABLE 355            ADVANCED WOUND CARE MARKET: REGION FOOTPRINT       279

TABLE 356            ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT       280

TABLE 357            ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT            281

TABLE 358            ADVANCED WOUND CARE MARKET: END USER FOOTPRINT       282

TABLE 359            ADVANCED WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES   285

TABLE 360            ADVANCED WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES                 285

TABLE 361            ADVANCED WOUND CARE MARKET: PRODUCT LAUNCHES AND APPROVALS,  JANUARY 2022–APRIL 2025                 288

TABLE 362            ADVANCED WOUND CARE MARKET: DEALS, JANUARY 2022–APRIL 2025            289

TABLE 363            ADVANCED WOUND CARE MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025                290

TABLE 364            ADVANCED WOUND CARE MARKET: OTHER DEVELOPMENTS,

JANUARY 2022–APRIL 2025            291

TABLE 365            SOLVENTUM: COMPANY OVERVIEW      292

TABLE 366            SOLVENTUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED    293

TABLE 367            SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 296

TABLE 368            SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            296

TABLE 369            SMITH+NEPHEW: COMPANY OVERVIEW                 298

TABLE 370            SMITH+NEPHEW: PRODUCTS/SOLUTIONS/SERVICES OFFERED    299

TABLE 371            SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–APRIL 2025            301

TABLE 372            SMITH+NEPHEW: DEALS, JANUARY 2022–APRIL 2025        302

TABLE 373            SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–APRIL 2025           302

TABLE 374            SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            302

TABLE 375            MÖLNLYCKE AB: COMPANY OVERVIEW                 304

TABLE 376            MÖLNLYCKE AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED    305

TABLE 377            MÖLNLYCKE AB: DEALS, JANUARY 2022–APRIL 2025        307

TABLE 378            MÖLNLYCKE AB: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            308

TABLE 379            CONVATEC GROUP PLC: COMPANY OVERVIEW                 309

TABLE 380            CONVATEC GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    310

TABLE 381            CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–APRIL 2025            311

TABLE 382            CONVATEC GROUP PLC: DEALS, JANUARY 2022–APRIL 2025           312

TABLE 383            COLOPLAST GROUP: COMPANY OVERVIEW                 313

TABLE 384            COLOPLAST GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED    314

TABLE 385            COLOPLAST GROUP: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–APRIL 2025            316

TABLE 386            COLOPLAST GROUP: DEALS, JANUARY 2022–APRIL 2025           316

TABLE 387            ORGANOGENESIS INC.: COMPANY OVERVIEW                 318

TABLE 388            ORGANOGENESIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    319

TABLE 389            ORGANOGENESIS INC.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–APRIL 2025            319

TABLE 390            ORGANOGENESIS INC.: EXPANSIONS, JANUARY 2022–APRIL 2025                319

TABLE 391            PAUL HARTMANN AG: COMPANY OVERVIEW                 320

TABLE 392            PAUL HARTMANN AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    321

TABLE 393            PAUL HARTMANN AG: DEALS, JANUARY 2022–APRIL 2025           323

TABLE 394            CARDINAL HEALTH: COMPANY OVERVIEW                 324

TABLE 395            CARDINAL HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED    325

TABLE 396            CARDINAL HEALTH: DEALS, JANUARY 2022–APRIL 2025           328

TABLE 397            CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–APRIL 2025                328

TABLE 398            MIMEDX GROUP, INC.: COMPANY OVERVIEW                 329

TABLE 399            MIMEDX GROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    330

TABLE 400            MIMEDX GROUP, INC.: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2022–APRIL 2025            330

TABLE 401            OWENS & MINOR: COMPANY OVERVIEW                 331

TABLE 402            OWENS & MINOR: PRODUCTS/SOLUTIONS/SERVICES OFFERED    332

TABLE 403            OWENS & MINOR: DEALS, JANUARY 2022–JANUARY 2025    332

TABLE 404            OWENS & MINOR: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            333

TABLE 405            B. BRAUN SE: COMPANY OVERVIEW       334

TABLE 406            B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED    335

TABLE 407            B. BRAUN SE: EXPANSIONS, JANUARY 2022–APRIL 2025           336

TABLE 408            B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            336

TABLE 409            ESSITY AKTIEBOLAG: COMPANY OVERVIEW                 337

TABLE 410            ESSITY AKTIEBOLAG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    338

TABLE 411            ESSITY AKTIEBOLAG: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            340

TABLE 412            INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW   341

TABLE 413            INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED    342

TABLE 414            INTEGRA LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS,  JANUARY 2022–APRIL 2025        343

TABLE 415            INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS,

JANUARY 2022–APRIL 2025            344

TABLE 416            AVERY DENNISON CORPORATION: COMPANY OVERVIEW          345

TABLE 417            AVERY DENNISON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED    346

TABLE 418            AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–APRIL 2025                347

TABLE 419            MATIV HOLDINGS, INC.: COMPANY OVERVIEW                 348

TABLE 420            MATIV HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    349

TABLE 421            MATIV HOLDINGS, INC.: DEALS, JANUARY 2022–APRIL 2025           350

TABLE 422            BIOVENTUS: COMPANY OVERVIEW        351

TABLE 423            BIOVENTUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED    352

TABLE 424            BIOVENTUS: DEALS, JANUARY 2022–JANUARY 2025        353

TABLE 425            BIOVENTUS: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025            353

TABLE 426            ZIMMER BIOMET: COMPANY OVERVIEW                 354

TABLE 427            ZIMMER BIOMET: PRODUCTS/SOLUTIONS/SERVICES OFFERED    355

TABLE 428            ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025        356

TABLE 429            LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW   357

TABLE 430            MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW          358

TABLE 431            DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW          359

TABLE 432            WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW          360

TABLE 433            ADVANCIS (UK): COMPANY OVERVIEW 361

TABLE 434            MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW          362

TABLE 435            PENSAR MEDICAL: COMPANY OVERVIEW                 363

TABLE 436            HAROMED BV: COMPANY OVERVIEW    364

TABLE 437            URGO GROUP: COMPANY OVERVIEW    365

TABLE 438            DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW          365

TABLE 439            DERMARITE INDUSTRIES, LLC.: COMPANY OVERVIEW          366

TABLE 440            GENTELL: COMPANY OVERVIEW              368

LIST OF FIGURES

FIGURE 1              ADVANCED WOUND CARE MARKET SEGMENTATION AND REGIONAL SCOPE              34

FIGURE 2              ADVANCED WOUND CARE MARKET: RESEARCH DESIGN                38

FIGURE 3              BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION     42

FIGURE 4              BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH              43

FIGURE 5              CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 44

FIGURE 6              ADVANCED WOUND CARE MARKET: TOP-DOWN APPROACH          45

FIGURE 7              DATA TRIANGULATION METHODOLOGY                 46

FIGURE 8              ADVANCED WOUND CARE MARKET, BY PRODUCT,  2025 VS. 2030 (USD MILLION)            49

FIGURE 9              ADVANCED WOUND CARE MARKET, BY WOUND TYPE,

2025 VS. 2030 (USD MILLION)      50

FIGURE 10            ADVANCED WOUND CARE MARKET, BY END USER,  2025 VS. 2030 (USD MILLION)      50

FIGURE 11            GEOGRAPHICAL SNAPSHOT OF ADVANCED WOUND CARE MARKET 51

FIGURE 12            INCREASING PREVALENCE OF DIABETES AND GROWING GERIATRIC POPULATION TO DRIVE MARKET                 53

FIGURE 13            HOSPITALS, ASCS, AND WOUND CARE CENTERS ACCOUNTED FOR LARGEST SHARE IN 2024          54

FIGURE 14            INDIA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030          55

FIGURE 15            ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD       55

FIGURE 16            ADVANCED WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          56

FIGURE 17            ADVANCED WOUND CARE MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 64

FIGURE 18            VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES      67

FIGURE 19            ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS              68

FIGURE 20            ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS  69

FIGURE 21            ADVANCED WOUND CARE MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2025          70

FIGURE 22            ADVANCED WOUND CARE MARKET: PATENT ANALYSIS,

JANUARY 2015–DECEMBER 2024               72

FIGURE 23            ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 83

FIGURE 24            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ADVANCED WOUND CARE PRODUCTS       85

FIGURE 25            KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS           85

FIGURE 26            AI USE CASES     87

FIGURE 27            NORTH AMERICA: ADVANCED WOUND CARE MARKET SNAPSHOT       189

FIGURE 28            ASIA PACIFIC: ADVANCED WOUND CARE MARKET SNAPSHOT       226

FIGURE 29            ADVANCED WOUND CARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS,

2022–2024              272

FIGURE 30            ADVANCED WOUND CARE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024               273

FIGURE 31            NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024             274

FIGURE 32            ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS OF

KEY PLAYERS, 2024           275

FIGURE 33            RANKING OF KEY PLAYERS IN ADVANCED WOUND CARE MARKET, 2024      275

FIGURE 34            ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       277

FIGURE 35            ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT       278

FIGURE 36            ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 284

FIGURE 37            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF

KEY VENDORS  286

FIGURE 38            EV/EBITDA OF KEY VENDORS   286

FIGURE 39            ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS     287

FIGURE 40            SOLVENTUM: COMPANY SNAPSHOT (2024)                 293

FIGURE 41            SMITH+NEPHEW: COMPANY SNAPSHOT (2024)                 299

FIGURE 42            MÖLNLYCKE AB: COMPANY SNAPSHOT (2024)                 305

FIGURE 43            CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024)    310

FIGURE 44            COLOPLAST GROUP: COMPANY SNAPSHOT (2024)    314

FIGURE 45            ORGANOGENESIS INC.: COMPANY SNAPSHOT (2024)    318

FIGURE 46            PAUL HARTMANN AG: COMPANY SNAPSHOT (2024)    321

FIGURE 47            CARDINAL HEALTH: COMPANY SNAPSHOT (2024)    325

FIGURE 48            MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2024)    329

FIGURE 49            OWENS & MINOR: COMPANY SNAPSHOT (2024)                 331

FIGURE 50            B. BRAUN SE: COMPANY SNAPSHOT (2024)                 335

FIGURE 51            ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024)    338

FIGURE 52            INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024)      342

FIGURE 53            AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024)             346

FIGURE 54            MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024)    349

FIGURE 55            BIOVENTUS: COMPANY SNAPSHOT (2024)                 352

FIGURE 56            ZIMMER BIOMET: COMPANY SNAPSHOT (2024)                 355

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧